Search

Your search keyword '"Simone IL"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Simone IL" Remove constraint Author: "Simone IL" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
43 results on '"Simone IL"'

Search Results

1. Adherence to riluzole in patients with amyotrophic lateral sclerosis: an observational study

2. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (vol 53, pg 1636, 2021)

Catalog

Books, media, physical & digital resources

3. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS

4. Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial

6. Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment

7. post marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in intereron beta treatment

8. rel-life impact of early interferon beta therapy in relapsing multiple sclerosis

11. Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomized, double blind, placebo controlled, phase III study

12. Real-life impact of early interferon beta therapy in relapsing multiple sclerosis

13. Brain atrophy and lesion load in a large population of patients with multiple sclerosis

14. FUS MUTATIONS IN SPORADIC AMYOTROPHIC LATERAL SCLEROSIS: CLINICAL AND GENETIC ANALYSIS

15. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis

16. Further evidence that D90A-SOD1 mutation is recessively inherited in ALS patients in Italy

17. Sporadic ALS is not associated with VAPB gene mutations in Southern Italy

18. Could mitochondrial haplogroups play a role in sporadic amyotrophic lateral sclerosis?

19. Acoustic Voice Analysis as a Useful Tool to Discriminate Different ALS Phenotypes.

20. Clinical Profiles and Patterns of Neurodegeneration in Amyotrophic Lateral Sclerosis: A Cluster-Based Approach Based on MR Imaging Metrics.

21. The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations.

22. Medulla oblongata volume as a promising predictor of survival in amyotrophic lateral sclerosis.

23. Individual Oligogenic Background in p.D91A- SOD1 Amyotrophic Lateral Sclerosis Patients.

24. Reduction of Sniff Nasal Inspiratory Pressure (SNIP) as an Early Indicator of the Need of Enteral Nutrition in Patients with Amyotrophic Lateral Sclerosis.

25. Influence of Pregnancy in Multiple Sclerosis and Impact of Disease-Modifying Therapies.

26. G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).

27. Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).

29. Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis.

30. Genome-wide Analyses Identify KIF5A as a Novel ALS Gene.

31. A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B.

33. Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study.

34. Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis.

35. Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis.

36. Influence of Interferon beta treatment on quality of life in multiple sclerosis patients.

37. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study.

38. Metabolic changes in neuronal migration disorders: evaluation by combined MRI and proton MR spectroscopy.

39. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.

40. Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.

42. Guillain-Barré syndrome after exogenous gangliosides in Italy.

43. A case of Landau-Kleffner syndrome secondary to inflammatory demyelinating disease.